BlackRock’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Buy |
|
|||||
|
2025
Q1 | $10.5M | Buy |
|
|||||
|
2024
Q4 | $8.35M | Buy |
|
|||||
|
2024
Q3 | $4.91M | Buy |
|
|||||
|
2024
Q2 | $5.07M | Buy |
|
|||||
|
2024
Q1 | $979K | Sell |
|
|||||
|
2023
Q4 | $892K | Buy |
|
|||||
|
2023
Q3 | $583K | Buy |
|
|||||
|
2023
Q2 | $162K | Buy |
|
|||||
|
2023
Q1 | $151K | Sell |
|
|||||
|
2022
Q4 | $51.5K | Buy |
|
|||||
|
2022
Q3 | $95K | Buy |
|
|||||
|
2022
Q2 | $109K | Sell |
|
|||||
|
2022
Q1 | $2.75M | Sell |
|
|||||
|
2021
Q4 | $3.43M | Buy |
|
|||||
|
2021
Q3 | $5.29M | Sell |
|
|||||
|
2021
Q2 | $7.96M | Buy |
|